I missed this at the time, in The Scottish Farmer, August 16th. As far as I can see nowhere in the MSM thought it news worth sharing.
Here’s what they said:
SCOTLAND REMAINS the envy of its UK counterparts in its efforts to eradicate bovine Tuberculosis (bTB), however, a post-EU era presents a new farming landscape and farmers have been urged not to get complacent in their efforts to control the disease. Scotland was officially granted bovine TB free status (OTF) from the EU in 2009 and with the exception of a few isolated incidents in the south-west and north-east parts of the country, this has stood strong for over a decade.
I’m reminded, leaping from one species to another like a virus, of this by reader Legerwood:
SCOTLAND LOSES ITS MEASLES-FREE STATUS DESPITE BEING MEASLES-FREE
The UK is losing its measles free status. For UK read England mainly. Matt Hancock, UK Health Secretary, talking at the weekend of compulsory immunisation of children before they start school. The immunisation figures for England are not great.
Here are the most recent figures for childhood immunisation in Scotland published 24th September 2019 by ISD Scotland
Childhood Immunisation Statistics Scotland
Uptake rates remain high in Scotland; over 95% of children had received each routine immunisation by the time they were 12 months of age, apart from rotavirus vaccine, which had 93.5% uptake.
Rotavirus vaccine helps to protect young children from infection that causes severe diarrhoea and vomiting. This vaccine should be given within the strict age limits of first dose before 15 weeks and second dose before 24 weeks of age. This short time window explains the slightly lower uptake rate.
The vast majority of children received their booster vaccines by 24 months of age; Hib/MenC (94.5%), Pneumococcal Conjugate Vaccine (PCV) (94.4%), MenB (93.7%).
Almost 94% of children had the first dose of MMR vaccine by 24 months of age. This rose to 97.0% for children who reached age five in the quarter ending June 2019, exceeding the 95% target.
Uptake of the second dose of MMR vaccine by five years was 91.3%, rising to 93.4% by age six years.